Last updated January 10, 2022

Diagnosis and Treatment of Non-Neurogenic Overactive Bladder in Adults

Updated Guideline Statement

Clinicians may consider combination therapy with an anti-muscarinic and β3-adrenoceptor agonist for patients refractory to monotherapy with either anti-muscarinics or β3-adrenoceptor agonists. (Conditional, B)
322859

Recommendation Grading

Overview

Title

Diagnosis and Treatment of Non-Neurogenic Overactive Bladder in Adults

Authoring Organizations

Publication Month/Year

September 1, 2019

Document Type

Guideline

External Publication Status

Published

Country of Publication

US

Document Objectives

The purpose of this guideline is to provide a clinical framework for the diagnosis and treatment of non-neurogenic overactive bladder (OAB).

Inclusion Criteria

Female, Male, Adult, Older adult

Health Care Settings

Ambulatory, Outpatient

Intended Users

Respiratory therapist

Scope

Diagnosis, Treatment

Diseases/Conditions (MeSH)

D014549 - Urinary Incontinence

Keywords

Urinary Incontinence, overactive bladder, void dysfunction